B. D’Abrosca et al. / Phytochemistry 65 (2004) 497–505
503
3.3.5. Oxidation of 2
1. The (S)-MTPA diester had the 1H NMR spectral
data (500 MHz, CDCl3): ꢀ 0.82 (3H, s, H-12), 0.88 (3H,
s, H-11), 1.42 (3H, d, J=6.0 Hz, H-10), 1.51 (1H, dd,
J=4.0 and 14.1 Hz, H-2a), 1.58 (3H, s, H-13), 1.84 (1H,
dd, J=6.0 and 14.1 Hz, H-2b), 2.25 (1H, d, J=8.0 Hz,
H-6a), 3.55 (3H, s, OMe), 3.56 (3H, s, OMe), 5.44 (1H,
dd, J=6.0 and 15.5 Hz, H-8), 5.47 (1H, dd, J=8.0 and
15.5 Hz, H-7), 5.49 (1H, m, H-3), 5.52 (1H, brs, H-4),
5.57 (1H, m, H-9), 7.40 (6H, m), 7.52 (4H, m). The (R)-
Active MnO2 (60 mg, 0.69 mmol) was added to a soln.
of 2 (6 mg, 28 mmol) in CHCl3 (0.8 ml). The reaction
mixture was kept under magnetic stirring at room
temperature. After 6 h, the reaction was filtered on SiO2
with CHCl3–Me2CO (19:1), and the residue was purified
on prep TLC eluting with CHCl3–Me2CO (19:1) to
1
obtain pure (6R)-4-megastigmen-3,9-dione (2 mg): H
NMR spectral data (500 MHz, CDCl3): ꢀ 1.02 (3H, s,
H-12), 1.07 (3H, s, H-11), 2.00 (3H, d, J =1.0, H-13),
2.05 (1H, d, J=17.5 Hz, H-2ax), 2.16 (3H, s, H-10), 2.37
(1H d, J=17.5 Hz, H-2eq), 5.83 (1H, s, H-4).
1
MTPA ester had the H NMR spectral data (500 MHz,
CDCl3): ꢀ 0.81 (3H, s, H-12), 0.83 (3H, s, H-11), 1.36
(3H, d, J=6.5 Hz, H-10), 1.44 (1H, dd, J=4.0 and 14.5
Hz, H-2a), 1.64 (3H, s, H-13), 1.82 (1H, dd, J=6.5 and
14.5 Hz, H-2b), 2.28 (1H, d, J=8.5 Hz, H-6a), 3.57 (6H,
s, OMe), 5.49 (1H, dd, J=6.5 and 15.0 Hz, H-8), 5.50
(1H, m, H-3), 5.52 (1H, dd, J=8.5 and 15.0 Hz, H-7),
5.55 (1H, m, H-9), 5.56 (1H, s, H-4), 7.40 (3H, m), 7.43
(3H, m), 7.52 (2H, m), 7.63 (3H, m).
3.3.6. Preparation of (S) and (R)-MTPA esters of 3
The (S) and (R)-MTPA esters of 3 were prepared
using the same procedure described for the compound
1
2. The (S)-MTPA ester had the H NMR spectral data
(500 MHz, CDCl3): ꢀ 0.92 (3H, s, H-12), 0.96 (3H, s, H-
11), 1.62 (1H, dd, J=4.0 and 14.3 Hz, H-2a), 1.65 (3H,
s, H-13), 1.94 (1H, dd, J=6.0 and 14.3 Hz, H-2b), 2.26
(3H, s, H-10), 2.46 (1H, d, J=10,0 Hz, H-6), 3.55 (3H,
s, OMe), 5.57 (1H, m, H-3), 5.60 (1H, brs, H-4), 6.08
(1H, d, J=15.8 Hz, H-8), 6.53 (1H, dd, J=10.0 and 15.8
Hz, H-7), 7.41 (3H, m), 7.54 (2H, m). The (R)-MTPA
ester had the 1H NMR spectral data (500 MHz,
CDCl3): ꢀ 0.88 (3H, s, H-12), 0.88 (3H, s, H-11), 1.49
(1H, dd, J=3.8 and 14.5 Hz, H-2a), 1.68 (3H, s, H-13),
1.87 (1H, dd, J=6.0 and 14.5 Hz, H-2b), 2.27 (3H, s, H-
10), 2.46 (1H, d, J=10,0 Hz, H-6), 3.56 (3H, s, OMe),
5.57 (1H, m, H-3), 5.65 (1H, brs, H-4), 6.08 (1H, d,
J=15.8 Hz, H-8), 6.52 (1H, dd, J=10.0 and 15.8 Hz, H-
7), 7.40 (3H, m), 7.53 (2H, m).
3.3.9. Preparation of (S) and (R)-MTPA diesters of 6
The (S) and (R)-MTPA diesters of 6 were prepared
using the same procedure described for the compound
1. The (S)-MTPA diester had the 1H NMR spectral
data (500 MHz, CDCl3): ꢀ 1.01 (3H, s, H-11), 1.10 (3H,
s, H-12), 1.47 (3H, d, J=6.1 Hz, H-10), 1.59 (1H, dd,
J=4.0 and 14.1 Hz, H-2ax), 1.82 (1H, dd, J=6.1 and
14.1 Hz, H-eq), 1.70 (3H, s, H-13), 2.23 (1H, dd, J=16.6,
10.2 Hz, H-4ax), 2.48 (1H, dd, J=16.6, 5.5 Hz, H-4eq),
5.31 (1H, m, H-3), 5.35 (1H, dd, J=6.0 and 15.5 Hz, H-
8), 3.55 (6H, s, OMe), 5.62 (1H, m, H-9), 6.10 (1H, dd,
J=8.0 and 15.5 Hz, H-7), 7.39 (6H, m), 7.52 (4H, m).
1
The (R)-MTPA diester had the H NMR spectral data
(500 MHz, CDCl3): ꢀ 1.04 (3H, s, H-11), 1.11 (3H, s, H-
12), 1.39 (3H, d, J=6.1 Hz, H-10), 1.66 (1H, m, H-2ax),
1.88 (1H, m, H-2eq), 1.67 (3H, s, H-13), 2.12 (1H, dd,
J=16.4, 9.9 Hz, H-4ax), 2.43 (1H, dd, J=16.4, 5.6 Hz,
H-4eq), 5.30 (1H, m, H-3), 5.39 (1H, dd, J=6.0 and 15.5
Hz, H-8), 3.55 (6H, s, OMe), 5.59 (1H, m, H-9), 6.15 (1H,
dd, J=8.0 and 15.5 Hz, H-7), 7.39 (6H, m), 7.50 (4H, m).
3.3.7. Preparation of (S) and (R)-MTPA esters of 4
The (S) and (R)-MTPA esters of 4 were prepared
using the same procedure described for the compound
1
2. The (S)-MTPA ester had the H NMR spectral data
(500 MHz, CDCl3): ꢀ 0.90 (3H, s, H-12), 1.00 (3H, s, H-
11), 1.43 (3H, d, J=6.0 Hz, H-10), 1.83 (3H, s, H-13),
2.05 (1H, d, J=16.5 Hz, H-2a), 2.23 (1H, d, J=16.5 Hz,
H-2b), 2.48 (1H, d, J=8.0 Hz, H-6a), 3.56 (3H, s,
OMe), 5.55 (1H, dd, J=6.0 and 15.5 Hz, H-8), 5.57 (1H,
m, H-9), 5.60 (1H, dd, J=8.0 and 15.5 Hz, H-7), 5.89
(1H, s, H-4), 7.39 (3H, m), 7.53 (2H, m). The (R)-MTPA
ester had the 1H NMR spectral data (500 MHz,
CDCl3): ꢀ 0.93 (3H, s, H-12), 1.02 (3H, s, H-11), 1.38
(3H, d, J=6.0 Hz, H-10), 1.86 (3H, s, H-13), 2.09 (1H,
d, J=17.0 Hz, H-2a), 2.29 (1H, d, J=17.0 Hz, H-2b),
2.53 (1H, d, J=9.0 Hz, H-6a), 3.52 (3H, s, OMe), 5.58
(1H, m, H-9), 5.65 (1H, dd, J=6.5 and 15.5 Hz, H-8),
5.72 (1H, dd, J=9.0 and 15.5 Hz, H-7), 5.91 (1H, s, H-
4), 7.40 (3H, m), 7.54 (2H, m).
3.3.10. Preparation of compound 7 from 6
Oxidation of 6. Active MnO2 (25 mg, 0.29 mmol) was
added to a soln. of 6 (5 mg, 24 mmol) in CHCl3 (0.5 ml).
The reaction mixture was kept under magnetic stirring
at room temperature. After 2 h, the reaction was filtered
on SiO2 with CHCl3–iso-PrOH (24:1) and the residue
was purified on prep TLC eluting with CHCl3–iso-
PrOH (24:1) to obtain pure (3R,7E)-3-hydroxy-5,7-
megastigmadien-9-one (2 mg). The oxidation product
13 had the 1H NMR spectral data (500 MHz, CDCl3): ꢀ
1.13 (3H, s, H-12), 1.14 (3H, s, H-11), 1.50 (1H, t,
J=12,2 Hz, H-2ax), 1.79 (3H, s, H-13), 1.80 (1H, m, H-
2eq), 2.10 (1H, dd, J=10.1 and 16.5 Hz, H-4ax), 2.32
(3H, s, H-10), 2.46 (1H, dd, J=8.0 and 16.5 Hz, H-4eq),
4.04 (1H, m H-3), 6.13 (1H, d, J=16.5 Hz, H-8), 7.22
(1H, d, J=16.5 Hz, H-7).
3.3.8. Preparation of (S) and (R)-MTPA diesters of 5
The (S) and (R)-MTPA esters of 5 were prepared
using the same procedure described for the compound